Date: 2017-12-22
Type of information: Services contract
Compound: digital data integration services
Company: Roche (Switzerland) Accenture (Ireland)
Therapeutic area: Technology - Services - Cancer - Oncology
Type agreement: services contract
Action mechanism:
Disease:
Details:
- • On December 22, 2017, Roche announced a collaborative services agreement with Accenture. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche's NAVIFY Tumor Board solution.
- A tumour board is a meeting in which multi-disciplinary healthcare teams review and discuss individual cancer patient cases and available treatment options. The NAVIFY Tumor Board solution streamlines and standardises the tumour board workflow process by aggregating relevant patient data from disparate IT systems into a software solution that fosters efficient team collaboration, reduces errors, and gives the care team more time to evaluate individual patient cases.
- The data integration capabilities Accenture provides will allow Roche to integrate patient data between hospitals and the NAVIFY Tumor Board solution to support clinicians in arriving at the best possible treatment decisions for their patients. The NAVIFY Tumor Board solution is built on a secure cloud platform.
- The NAVIFY Tumor Board solution is currently available in the US, UK, Germany, Spain, Sweden, Switzerland, and the Netherlands.
Financial terms:
Latest news:
Is general: Yes
